LGND Ligand Pharmaceuticals
- 105.800
- -0.060-0.06%
- 105.800
- 0.0000.00%
Ligand Pharmaceuticals News
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
144: Notice of proposed sale of securities pursuant to Rule 144
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ligand Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Ligand Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Ligand Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Ligand Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Analysis
Price Target
No Data
